Treatment with a demethylase and/or HDAC inhibitor did not increase SLFN11 expression, and demethylation with decitabine did not improve SCLC cell lines’ sensitivity to cisplatin or PARP inhibitors (data not shown). The gene discussed is SLFN11; the disease is small cell lung carcinoma.